Niki BioSolutions, Inc. (NIKI) stock
NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2025, quý kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 4/30
$1.60+0.10 (+6.67%)
Close on Nov 18, 2026Market cap $13.03MP/E –Yield –
Niki BioSolutions gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2023 it was 2.4%, against 6.2% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 2.4% | −3.7 |
| FY2022 | Dec 31, 2022 | 6.2% | +0.9 |
| FY2021 | Dec 31, 2021 | 5.3% | – |
See a number that looks wrong?